In a patient with diphenhydramine (Benadryl) overdose and prolonged QTc who remains severely agitated after a 1 mg IV dose, what medication should be given to control agitation without further prolonging the QT interval?

Benzodiazepines are the safest choice for severe agitation in diphenhydramine overdose with prolonged QTc

In a patient with diphenhydramine overdose and prolonged QTc who remains severely agitated despite initial treatment, use benzodiazepines (lorazepam 2-4 mg IV or midazolam 5 mg IM) as first-line therapy, avoiding all antipsychotics except aripiprazole if absolutely necessary.

Rationale and Clinical Approach

Why Avoid Most Antipsychotics

The 2023 Canadian Cardiovascular Society guidelines emphasize that when a patient is already taking a QTc-prolonging drug (diphenhydramine in this case), adding another QTc-prolonging medication should be avoided 1. The guidelines specifically note that antipsychotics/antidepressants are among the "anti's" that commonly prolong QTc and increase risk of torsades de pointes (TdP), particularly when QTc exceeds 500 ms 1.

Diphenhydramine overdose itself causes QTc prolongation through potassium channel inhibition 2. A recent case report documented TdP occurring in a patient with diphenhydramine overdose and QTc of 480 ms, requiring cardioversion 3. This underscores the real mortality risk in this scenario.

Preferred Medication Strategy

First-line: Benzodiazepines

• Lorazepam 2-4 mg IV or midazolam 5 mg IM are the safest options
• Benzodiazepines do not prolong QTc interval 4
• Effective for agitation across multiple etiologies 5
• Can be repeated every 15-30 minutes as needed

Second-line (if benzodiazepines inadequate): Aripiprazole

• Among antipsychotics, aripiprazole has minimal to no QTc prolongation risk 6, 7
• Dose: 5-10 mg IM (though oral may be only available option)
• Recent case series support its use even in congenital long QT syndrome 8
• Other atypical antipsychotics (olanzapine, quetiapine, risperidone) cause moderate QTc prolongation and should be avoided in this context 7

Avoid completely:

• Haloperidol (even though widely used, it prolongs QTc) 5
• Ziprasidone (highest QTc prolongation among atypicals) 7, 5
• Typical antipsychotics like chlorpromazine or droperidol

Risk Stratification Based on QTc

The guidelines provide clear thresholds 1:

• QTc < 500 ms: Benzodiazepines preferred; aripiprazole, olanzapine, risperidone, or quetiapine acceptable if needed 6
• QTc ≥ 500 ms: Limit to benzodiazepines, aripiprazole, or adjunctive valproate/trazodone 6
• Risk increases when QTc increases by >60-70 ms from baseline 1

Critical Pitfalls to Avoid

1. Do not assume tachycardia is protective: While one case report suggested diphenhydramine-induced tachycardia might protect against TdP 2, another case demonstrated TdP occurring despite this theoretical protection 3

2. Monitor electrolytes aggressively: Correct hypokalemia and hypomagnesemia immediately, as these synergistically increase TdP risk with QTc-prolonging drugs 1

3. Serial ECG monitoring: Obtain ECGs every 2-4 hours until QTc normalizes and agitation resolves

4. Avoid combination therapy with multiple QTc-prolonging agents: The additive effect dramatically increases arrhythmia risk 1

Practical Algorithm

1. Immediate: Lorazepam 2-4 mg IV (or midazolam 5 mg IM if no IV access)
2. If inadequate response in 15-30 minutes: Repeat benzodiazepine dose
3. If still inadequate after 2-3 doses: Consider aripiprazole 5-10 mg IM/PO
4. Throughout: Correct electrolytes, continuous cardiac monitoring, serial ECGs
5. Avoid: All other antipsychotics given the existing QTc prolongation from diphenhydramine

This approach prioritizes mortality prevention (avoiding TdP) while effectively managing the agitation that threatens patient and staff safety.